Statistical considerations when using a composite endpoint for comparing treatment groups. [electronic resource]
Producer: 20130906Description: 719-38 p. digitalISSN:- 1097-0258
- AIDS Vaccines -- administration & dosage
- Acute Coronary Syndrome -- complications
- Anti-HIV Agents -- administration & dosage
- Anticholesteremic Agents -- therapeutic use
- Biostatistics -- methods
- Endpoint Determination -- statistics & numerical data
- HIV Infections -- drug therapy
- Humans
- Probucol -- analogs & derivatives
- Randomized Controlled Trials as Topic -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.